
Release date: 2024-08-22 17:14:22 Article From: Lucius Laos Recommended: 251
Anamorelin is a ghrelin receptor agonist used to treat cancer cachexia and significantly improve patients' quality of life by increasing appetite and weight.
When using Anamorelin, it is necessary to pay attention to possible drug interactions.
Both Anamorelin and anthracyclines have sodium channel inhibition and may increase the risk of cardiotoxicity when used concomitantly, so they need to be used with special caution.
Drugs such as clarithromycin, voriconazole, itraconazole, ibuprofen, ritonavir, cabozidine have a strong inhibitory effect on CYP3A4 and can hinder the metabolism of anamolin, leading to an increase in drug concentration and increasing the risk of side effects and adverse reactions.
Understanding these drug interactions can help reduce the risk when using Anamorelin. Next, we will explore in detail the possible adverse effects of Anamorelin.
During the use of Anamorelin, patients may experience some adverse reactions. Common adverse effects include the following:
Anamolin may cause impaired liver function, manifested by elevated liver enzymes or abnormal liver function. It is recommended to monitor liver function regularly and inform your doctor immediately if you notice any abnormalities.
Some patients may feel weakened muscle strength when using Anamorelin, affecting daily activities. When this happens, you should discuss what to do with your doctor as soon as possible.
Understanding these adverse effects can help to respond to and manage them in a timely manner. Next, we'll explore what you need to look out for when using anamorin.
When using anamorin, there are a few important things to keep in mind:
In patients with a history of anthracycline use, there is cumulative cardiotoxicity with the drug, and serious side effects may occur.
Anamolin may inhibit sodium channels, resulting in ECG abnormalities such as PR interval, QRS interval, or QT interval prolongation. ECG, pulse, blood pressure, and electrolyte levels should be monitored regularly before and during treatment. If there is an abnormality, the drug should be stopped immediately.
Understanding these considerations can help you better manage your medication process. If in doubt or unwell, consult a physician promptly.
[Warm tips] When using Anamorelin, please check the electrocardiogram and electrolyte levels regularly, and contact your doctor immediately if you find any abnormalities. Pay attention to your body's response to ensure that the treatment goes smoothly.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:2622025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:4832024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:2672025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:2772025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:2582025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:3032025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:2652025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:2442025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: